MMM3M CO
Surgical & Medical Instruments & Apparatus
- Revenue
- $24.9B
- 1.5% YoY
- Operating margin
- 18.6%
- 5.4% YoY
- EBITDA
- $5.9B
- 4.0% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 2.2×
- $12.8B net debt
- AI in 10-K
- —
Red flags 2 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashFired71% of net incomeCash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowFired209% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear19% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $35.4B | $26.2B | $24.6B | $24.6B | $24.9B | 1.5% |
| Operating income | $7.4B | $4.4B | −$10.7B | $4.8B | $4.6B | 4.0% |
| Net income | $5.9B | $5.8B | −$7.0B | $4.2B | $3.3B | 22% |
| Operating cash flow | $7.5B | $5.6B | $6.7B | $1.8B | $2.3B | 27% |
| Capex | $1.6B | $1.7B | $1.6B | $1.2B | $910M | 23% |
| Stock-based comp | $274M | $263M | $274M | $289M | $225M | 22% |
| Buybacks | $2.2B | $1.5B | $33M | $1.8B | $3.3B | 81% |
| Dividends | $3.4B | $3.4B | $3.3B | $2.0B | $1.6B | 21% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.